@FiercePharma: Sinovac close to China marketing approval for hand, foot and mouth vaccine. More from FiercePharmaAsia | Follow @FiercePharma
@EricPFierce: Malaysia's CCM Duopharma Biotech ready to compete with the big boys, buying 6 plants from parent. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Imbruvica cocktail stalls CLL in new trial, raising hopes for bigger market. Article | Follow @CarlyHFierce
> The FDA approved Cholbam, a new drug from Baltimore-based Asklepion Pharmaceuticals, to treat bile acid and peroxisomal disorders in kids and adults. Release
> Australia's expert body that recommends drugs for subsidy has hit back at a pharmaceutical industry push to fast-track listings for new cancer medicines. Report
> Illinois drugmaker Akorn ($AKRX) has asked Alabama officials to return any Akorn-made drugs the state may be planning to use in executions by lethal injection. Report
> Pfizer's ($PFE) court fight over Lipitor discounting in Australia isn't over yet; the country's consumer watchdog says it will appeal a federal judge's decision that the company hadn't engaged in anticompetitive conduct. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: Mayo Clinic finds a common MRI contrast agent is deposited in the brain. Report | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: Tablets, apps being deployed to improve customer service in the ICU. Article | Follow @VarunSaxena2
@EmilyWFierce: $MDT and the University of Minnesota are studying hibernating bears to gain insight into treating heart disease. More | Follow @EmilyWFierce
> Olympus faces more legal pushback over endoscopes linked to UCLA superbug outbreak. Article
> Vivo Capital doubles down to close $750M U.S.-China healthcare fund. Story
> Boston Scientific implantable defibrillator gets FDA green light. Report
Biotech News
@FierceBiotech: ICYMI yesterday: Struggling GlaxoSmithKline warns of 150 R&D job cuts in Philadelphia. News | Follow @FierceBiotech
@JohnCFierce: Pfizer joins a powerhouse syndicate backing $43M round for Nimbus. News | Follow @JohnCFierce
@DamianFierce: Dear Twitter, it is my great honor to introduce FierceMadness, the 2015 Drug Name Tournament. Check it out | Follow @DamianFierce
> Retrophin bags rare disease approval, FDA voucher in $75M deal. News
> Nordic Nanovector upscales IPO as demand tops expectations. More
> Deep dive into Actelion's Uptravi data calms investors as FDA decision date nears. Story
> Nektar looks for the positive in a failed PhIII breast cancer study. Report
Biotech Research News
> Research group uses nanoparticles to deliver antibiotic. Item
> Fast-spreading CRISPR tech inspires new preclinical work on blood cancers. More
> Academic team assembles a 'homegrown' immunotoxin for blood cancers. Story
> Blood pressure drug looks promising in preventing myelin loss in MS. Article
> Rockefeller U team touts a potential psoriasis 'cure' from Boehringer. Report
Diagnostics News
> Metabolon rides on last year's success with $5M in extended financing. Story
> Illumina hits U.K. company with prenatal test patent suit. Article
> Myriad extends collaboration with BioMarin for cancer companion Dx. Item
> Invitae to focus on adding genetic tests, securing reimbursement in 2015. Report
> 23andMe launches new therapeutics group with biotech vet taking the reins. More
Pharma Marketing News
> Worried about quality at home, Chinese consumers stock up on 'Made in Japan' drugs. Item
> Judge tosses Xolair kickback suit against Novartis, Genentech. Report
> Pernix looks for a sales trifecta from 100 new Zohydro reps. Story
> Mayo docs join the revolt against rising cancer drug prices. News
> It had to happen: Apple Watch gets a drug-adherence app. More
And Finally... Aspirin may increase the risk of colorectal cancer in people with certain genetic variants, new research shows. Report